• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about TLSA

Recent news which mentions TLSA

< Previous 1 2 3 4 Next >
Don't Get Caught In Equity Rally Hype: Lessons From 2023 To Remember In 2024
December 12, 2023
Tickers AAPL AMZN FOMO GOOGL
Tags TLSA FOMO AAPL
From Benzinga
Tiziana Expects To Start Enrolling Patients In Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using Its Novel Intranasal Monoclonal Antibody Foralumab
November 30, 2023
Tickers TLSA
Tags Biotech Benzinga Partner Content
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 19, 2023
Tickers AIP ATNF BCEL BSFC
Tags NXU ATNF OTLK
From InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 18, 2023
Tickers AKAN AKLI BCEL BPTH
Tags NMRD NMTC AKAN
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 18, 2023
Tickers ADN ARAV BCEL BIOC
Tags NUZE IONM BCEL
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 17, 2023
Tickers ANEB ASMB BTTX CELC
Tags BZI/TFM OLK Benzinga
From Benzinga
Tiziana To Announce Six-Month Human Safety And Biomarker Data At The ECTRIMS Annual Congress, Following-Up From Positive Outcomes Data Presented In June
October 12, 2023
Tickers TLSA
Tags TLSA Penny Stocks Market News
From Benzinga
Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update
October 04, 2023
Tickers RHHBY SNY TLSA
Tags Partner Content Benzinga RHHBY
From Benzinga
Tiziana Life Sciences Prepares To Advance Lead Intranasal Foralumab Program In First-Of-Its-Kind Phase 2a Clinical Trial for Non-Active SPMS Patients
September 27, 2023
Tickers TLSA
Tags Biotech Benzinga Tiziana Life Sciences
From Benzinga
Tesla Cybertruck To Be Used For Oracle's Next-Gen Police Car
September 20, 2023
Tickers EVS ORCL TECH TLSA
Tags TLSA law enforcement Market News
From Benzinga
Tiziana Reveals Alzheimer's Research Milestone With PNAS Journal After FDA IND Green Light
September 12, 2023
Tickers TLSA
Tags General Tiziana Life Sciences Market News
From Benzinga
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
September 06, 2023
Tickers ABOS BIIB LGVN TLSA
Tags TLSA ABOS Penny Stocks
From Benzinga
Tiziana's Intranasal Foralumab For Alzheimer's Treatment Gets FDA Nod For Phase 2 Trials Under Brigham And Women's Hospital Supervision
August 16, 2023
Tickers TLSA
Tags Biotech Benzinga TLSA
From Benzinga
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 15, 2023
Tickers AAMC AEY AKTX AREN
Tags CALT OPRX Small Cap
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 15, 2023
Tickers BBLG DCTH DSGN GLTO
Tags DCTH OPRX Market News
From Benzinga
Nvidia climbs, D.R. Horton gets a Buffett boost, and other stocks on the move
August 15, 2023
Tickers AMC BK BRK-A BRK-B
Tags COF DFS NVDA
From MarketWatch
Why Tiziana Life Sciences Stock (TLSA) Is Climbing
August 15, 2023
Tickers TLSA
Tags News TLSA Movers
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 15, 2023
Tickers DCTH DSGN EVOK GLTO
Tags EVOK GLTO GMVD
From Benzinga
As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab?
August 08, 2023
Tickers BAYRY SNY TLSA
Tags Partner Content Benzinga Biotech
From Benzinga
Tiziana (NASDAQ: TLSA) Continues The Fight Against Multiple Sclerosis, Will Announce 6-Month Results For Its Novel Treatment Soon
August 03, 2023
Tickers SNY TLSA
Tags Benzinga Biotech Partner Content
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 01, 2023
Tickers ADMP APLM CMPX MDXG
Tags PEN RVLP NBSE
From Benzinga
Publications And Positive Data From Multiple Trials: Six Months In Review For Tiziana Life Sciences (NASDAQ: TLSA)
July 10, 2023
Tickers SNY TLSA
Tags Tiziana Life Sciences General SNY
From Benzinga
Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company?
June 15, 2023
Tickers PRVB SNY TLSA
Tags SNY General Tiziana Life Sciences
From Benzinga
Tiziana's Foralumab Shown To Reduce Microglial Activation In MS Patients; Phase 2a Trial To Begin In Q3 2023
June 06, 2023
Tickers TLSA
Tags Biotech Benzinga General
From Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 25, 2023
Tickers AAN ACON AGFY ARWR
Tags Small Cap Top Gainers Mid/Day Movers
From Benzinga
Tiziana Life Sciences To Submit Alzheimer's IND In Q2 2023, Seeks $3 Million From An Alzheimer's Foundation To Support Phase 2a Trial
April 21, 2023
Tickers TLSA
Tags TLSA Market News Penny Stocks
From Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
April 19, 2023
Tickers EWTX IPHA PRVB SGEN
Tags Penny Stocks Tiziana Life Sciences General
From Benzinga
EXCLUSIVE: Tiziana Life Sciences Plans To Develop Multiple Sclerosis Hopeful For Long COVID Patients
April 13, 2023
Tickers TLSA
Tags Market/Moving Exclusives General News
From Benzinga
Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise
April 12, 2023
Tickers PRVB SNY TLSA
Tags General Tiziana Life Sciences SNY
From Benzinga
Tiziana Receives Sign-Off From The FDA To Proceed With Phase 2 Clinical Trial In Patients With Non-Active Secondary Progressive Multiple Sclerosis (SPMS)
March 29, 2023
Tickers TLSA
Tags News General Tiziana Life Sciences
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap